Duchenne UK, SMA UK and University of Liverpool win £1.25m award for revolutionary mobility suit, funded by players of People’s Postcode Lottery

Read More

World Muscle Society issues new COVID-19 guidance for people with neuromuscular diseases

The World Muscle Society has issued new advice on COVID-19 for people living with neuromuscular diseases such as DMD.

Read More

Duchenne UK funds new technique for finding effective DMD treatments

Duchenne UK has funded a three-year research project to investigate drugs that could delay muscle degeneration. 

Read More

How young people with Duchenne muscular dystrophy can get involved in sport

Staying active and being part of a team can have huge benefits for young people with DMD. We spoke to people in the DMD community about the sports they play and how you can get involved.

Read More

DMD Hub launches pilot project to improve access to research studies

Duchenne UK and the DMD Hub are launching a new pilot project aiming to provide fair and equal access to DMD trials across the UK

Read More

2021 impact report

Read about all we achieved with your support in 2021 in our latest impact report

Read More

Duchenne UK launch In Case of Emergencies App

Duchenne UK has launched a new mobile app that could help to save DMD patients’ lives in medical emergencies.  

Read More

Disappointing findings in anti-inflammatory drug repurposing project

Duchenne UK is disappointed to announce that a project investigating the potential of montelukast, an existing anti-inflammatory drug for asthma, to treat DMD failed to show benefit in a pre-clinical study.

Read More

COVID-19 spring booster: what we know so far

This week, the Joint Committee on Vaccination and Immunisation (JCVI) recommended immunosuppressed people aged 12 and over get a ‘spring booster’ of the COVID-19 vaccine six months after their most recent dose.

Read More